Transforming PCI: mastering the implementation of drug-eluting balloons

Sponsored by Cordis

Anchorperson: A. Colombo

Spokesperson: B. Vaquerizo

Summary

This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and complex coronary lesions. The session highlights the mechanistic advantages of drug selection and sustained drug release technologies, with a focus on the SELUTION SLR DEB. Clinical updates include the LOVE-DEB study advocating a DEB-first approach in large vessel coronary artery disease, real-world performance data from the Malaysian registry, and practical case examples illustrating the transition to DEB-based PCI in clinical practice.

Learning Objectives

To understand the evidence and rationale behind drug-eluting balloons (DEBs)
To explore the clinical data supporting the use of DEBs in modern PCI
To discover how DEBs minimise metal implantation and effectively manage both standard and complex lesions
To learn more about the mechanistic rationale and merits of drug choice